«Urethra

Below is an extended Urethra patents listing. Click here to return to the Urethra main in depth entry.

Patents :
US Patent No.	Title
7414063	Inhibitors of Akt (protein kinase B)
7419482	Systems and methods for delivering agents into targeted tissue of a living being
7419500	Device for thermal ablation of a cavity
7419696	Medical devices for delivering a therapeutic agent and method of preparation
7419785	Methods and compositions in breast cancer diagnosis and therapeutics
7419988	Azaindole inhibitors of aurora kinases
7419999	Gamma lactams as prostaglandin agonists and use thereof
7420099	Transgenic animals and uses thereof
7422557	Needle design for male transobturator sling
7422583	Cryo-surgical apparatus and method of use
7422858	Apparatus and method for separating viral particles from cells
7419376	Human tissue phantoms and methods for manufacturing thereof
7417740	Single trace multi-channel low coherence interferometric sensor
7414170	Transgenic bovines capable of human antibody production
7415301	Therapeutic system
7415308	Implantable medical device providing adaptive neurostimulation therapy for incontinence
7416549	Multi-zone bipolar ablation probe assembly
7416558	Drug-eluting stent cover and method of use
7416559	Micromantled drug-eluting stent
7416885	Proliferated cell lines and uses thereof
7417048	Aryl-substituted derivatives of cycloalkyl and branched chain alkyl carboxylic acids useful as antinociceptive drugs for peripheral targets
7417113	PSCA: prostate stem cell antigen and uses thereof
7417175	Interstitial prostatism model animal
7422871	Uropathogenic E. coli D-serine detoxification operon
7424780	Device for cutting sanitary containers, in particular sacks, bags, and/or pouches for stomas
7425200	Implantable sensor with wireless communication
7429490	Tissue engineered uterus
7429595	Acyl and sulfonyl derivatives of 6,9-disubstituted 2-(trans-1,4-diaminocyclohexyl)-purines and their use as antiproliferative agents
7429650	Methods and compositions in breast cancer diagnosis and therapeutics
7429673	TRPV1 agonists, formulations containing them and uses thereof
7429690	Transgenic bovines having reduced prion protein production
7431690	Implantable sling for the treatment of male incontinence and method of using the same
7431701	Method and system for diagnosis of lower urinary tract dysregulation and related conditions
7431732	Stent with waved connecting members
7432241	Device for treating diabetes and methods thereof
7432346	Gene expressed in prostate cancer
7429488	Method for processing lipoaspirate cells
7429387	Use of botulinum toxin therapy for treatment of recalcitrant voiding dysfunction
7425212	Devices for modification of airways by transfer of energy
7425217	System and method for inhibiting cellular proliferation with tachykinins
7425544	Modulation of eIF4E expression
7425637	N3 alkylated benzimidazole derivatives as MEK inhibitors
7427265	Endoluminal implant with therapeutic and diagnostic capability
7427280	Method, system and device for treating disorders of the pelvic floor by delivering drugs to various nerves or tissues
7427605	Inhibitors of ribonucleotide reductase subunit 2 and uses thereof
7427637	Mitotic kinesin inhibitors
7429240	Device for depositing items into tissue
7429262	Apparatus and methods for electrosurgical ablation and resection of target tissue
7433734	Apparatus and method for blocking activation of tissue or conduction of action potentials while other tissue is being therapeutically activated

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.